Pain Practice最新文献

筛选
英文 中文
Utilizing a learning health system to capture real-world patient data: Application of the reliable change index to evaluate and improve the outcome of a pain rehabilitation program. 利用学习型医疗系统获取真实世界的患者数据:应用可靠的变化指数来评估和改善疼痛康复计划的成果。
IF 2.5 3区 医学
Pain Practice Pub Date : 2024-07-01 Epub Date: 2024-03-11 DOI: 10.1111/papr.13364
Dokyoung S You, Jeanette L Chong, Sean C Mackey, Heather Poupore-King
{"title":"Utilizing a learning health system to capture real-world patient data: Application of the reliable change index to evaluate and improve the outcome of a pain rehabilitation program.","authors":"Dokyoung S You, Jeanette L Chong, Sean C Mackey, Heather Poupore-King","doi":"10.1111/papr.13364","DOIUrl":"10.1111/papr.13364","url":null,"abstract":"<p><strong>Background and objectives: </strong>The learning healthcare system (LHS) has been developed to integrate patients' clinical data into clinical decisions and improve treatment outcomes. Having little guidance on this integration process, we aim to explain (a) an applicable analytic tool for clinicians to evaluate the clinical outcomes at a group and an individual level and (b) our quality improvement (QI) project, analyzing the outcomes of a new outpatient pain rehabilitation program (\"Back-in-Action\": BIA) and applying the analysis results to modify our clinical practice.</p><p><strong>Methods: </strong>Through our LHS (CHOIR; https://choir.stanford.edu), we administered the Pain Catastrophizing Scale (PCS), Chronic Pain Acceptance Questionnaire (CPAQ), and Patient-Reported Outcomes Measures (PROMIS)® before and after BIA. After searching for appropriate analytic tools, we decided to use the Reliable Change Index (RCI) to determine if an observed change in the direction of better (improvement) or worse (deterioration) would be beyond or within the measurement error (no change).</p><p><strong>Results: </strong>Our RCI calculations revealed that at least a 9-point decrease in the PCS scores and 10-point increase in the CPAQ scores would indicate reliable improvement. RCIs for the PROMIS measures ranged from 5 to 8 T-score points (i.e., 0.5-0.8 SD). When evaluating change scores of the PCS, CPAQ, and PROMIS measures, we found that 94% of patients showed improvement in at least one domain after BIA and 6% showed no reliable improvement.</p><p><strong>Conclusions: </strong>Our QI project revealed RCI as a useful tool to evaluate treatment outcomes at a group and an individual level, and RCI could be incorporated into the LHS to generate a progress report automatically for clinicians. We further explained how clinicians could use RCI results to modify a clinical practice, to improve the outcomes of a pain program, and to develop individualized care plans. Lastly, we suggested future research areas to improve the LHS application in pain practice.</p>","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11415933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benzodiazepines and mortality: Consideration of potential confounders. 苯二氮卓类药物与死亡率:考虑潜在的混杂因素。
IF 2.5 3区 医学
Pain Practice Pub Date : 2024-07-01 Epub Date: 2024-02-27 DOI: 10.1111/papr.13356
Brendan Jen-Wei Tan, Eng-King Tan, Bin Xiao
{"title":"Benzodiazepines and mortality: Consideration of potential confounders.","authors":"Brendan Jen-Wei Tan, Eng-King Tan, Bin Xiao","doi":"10.1111/papr.13356","DOIUrl":"10.1111/papr.13356","url":null,"abstract":"","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139972991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on Retrograde thoracic spinal cord stimulation paddle placement for complex persistent spinal pain syndrome type 2. 关于逆行胸椎脊髓刺激桨置入治疗复杂性持续性脊髓疼痛综合征 2 型的评论。
IF 2.5 3区 医学
Pain Practice Pub Date : 2024-07-01 Epub Date: 2024-03-04 DOI: 10.1111/papr.13357
Peng-Bo Zhou, Hong-Tao Sun
{"title":"Comments on Retrograde thoracic spinal cord stimulation paddle placement for complex persistent spinal pain syndrome type 2.","authors":"Peng-Bo Zhou, Hong-Tao Sun","doi":"10.1111/papr.13357","DOIUrl":"10.1111/papr.13357","url":null,"abstract":"","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triptan treatment is associated with a higher number of red wine-induced migraine episodes: An exploratory questionnaire-based survey. 服用阿普唑仑与红葡萄酒诱发偏头痛发作次数增加有关:一项基于问卷的探索性调查。
IF 2.5 3区 医学
Pain Practice Pub Date : 2024-07-01 Epub Date: 2024-03-07 DOI: 10.1111/papr.13365
Laura Nedergaard, Maria Celine Martens, Michala Daniela Bach Christensen, Lanfranco Pellesi
{"title":"Triptan treatment is associated with a higher number of red wine-induced migraine episodes: An exploratory questionnaire-based survey.","authors":"Laura Nedergaard, Maria Celine Martens, Michala Daniela Bach Christensen, Lanfranco Pellesi","doi":"10.1111/papr.13365","DOIUrl":"10.1111/papr.13365","url":null,"abstract":"<p><strong>Aim: </strong>Diet, including foods and beverages, affects migraine. Conversely, the influence of migraine therapies on dietary habits is largely unknown. This study aimed at investigating the effects of triptan intake on foods and drinks consumed by adults with migraine with and/or without aura.</p><p><strong>Methods: </strong>An exploratory questionnaire-based survey took place online between November 2022 and June 2023. Participants were recruited through advertisements shared on social media accounts (e.g., Facebook and Instagram) and seasonal newsletters of three Danish patient associations. In addition, posters and flyers in headache and pain centers at Danish hospitals and private neurological, pain, and physiotherapeutic clinics were utilized.</p><p><strong>Results: </strong>A total of 314 adults with migraine with and/or without aura completed the survey. Among the respondents, 236 individuals (75.2%) regularly used triptans to treat their migraines. Compared with non-triptan users, individuals using triptans were characterized by significantly more foods and/or drinks triggering migraine (74.2% vs. 56.4%, p = 0.005). Alcoholic beverages and most specifically red wine were overreported as migraine triggers by triptan users (48.3% vs. 21.8%, p < 0.001). In the week preceding the survey, red wine was significantly less consumed by triptan users than non-triptan users (92.4% vs. 76.9%, p < 0.001).</p><p><strong>Conclusions: </strong>Patients who regularly consume triptans report red wine most frequently as a migraine trigger. Triptan users are characterized by a lower consumption of red wine than non-triptan users, suggesting that a regular triptan intake may promote an increased sensitivity to red wine-induced migraine.</p>","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P/Q-type calcium channel antibody-associated headache disorder (P/Q-HaND). P/Q型钙通道抗体相关性头痛症(P/Q-HaND)。
IF 2.5 3区 医学
Pain Practice Pub Date : 2024-07-01 Epub Date: 2024-03-07 DOI: 10.1111/papr.13366
Andreas Posa, Malte Kornhuber
{"title":"P/Q-type calcium channel antibody-associated headache disorder (P/Q-HaND).","authors":"Andreas Posa, Malte Kornhuber","doi":"10.1111/papr.13366","DOIUrl":"10.1111/papr.13366","url":null,"abstract":"","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
10 kHz stimulation as rescue therapy for spinal cord stimulation trial failure or loss of efficacy: A retrospective study. 将 10 kHz 刺激作为脊髓刺激试验失败或疗效丧失的挽救疗法:回顾性研究。
IF 2.5 3区 医学
Pain Practice Pub Date : 2024-07-01 Epub Date: 2024-04-01 DOI: 10.1111/papr.13369
Pasquale Buonanno, Giuseppe Servillo, Veerle Visser-Vandewalle, Georgios Matis
{"title":"10 kHz stimulation as rescue therapy for spinal cord stimulation trial failure or loss of efficacy: A retrospective study.","authors":"Pasquale Buonanno, Giuseppe Servillo, Veerle Visser-Vandewalle, Georgios Matis","doi":"10.1111/papr.13369","DOIUrl":"10.1111/papr.13369","url":null,"abstract":"<p><strong>Introduction: </strong>Spinal cord stimulation (SCS) is currently used for the management of pain of different origin, and since its inception, many waveforms have been developed. Some patients experience no pain relief already during SCS trial, while other patients go through a loss of efficacy due to habituation after a variable period of satisfying pain control. Our retrospective study represents the first report exploring the potential role of 10 kHz stimulation as rescue therapy for patients who did not benefit not only from conventional stimulation but even from other waveforms during SCS trial or follow-up.</p><p><strong>Methods: </strong>This study was conducted in Germany; we retrospectively enrolled patients with no pain relief during SCS trial or with loss of efficacy of other waveforms over time; and we recorded visual analogic scale (VAS), Oswestry Disability Index (ODI), and daily opioid consumption expressed as morphine milligram equivalents (MME), right before and 12 months after the switching to 10 kHz simulation.</p><p><strong>Results: </strong>The rate of successful switching to 10 kHz stimulation was comparable in patients enrolled during the SCS trial and during the follow-up (43% vs. 40%, respectively); notably, the highest rate of failed rescue was recorded in case of persistent spinal pain syndrome (PSPS) II. Patients who responded to the switching showed a significant improvement in VAS and ODI after 12 months of treatment compared to baseline (3.6 ± 1.0 vs. 8.2 ± 0.9, p < 0.00001 and 34.0 ± 7.8 vs. 64.3 ± 8.7, p < 0.0001, respectively), whereas there was no reduction in the consumption of opioids in terms of MME (3 (0-16) vs. 5 (0-8.75), p = 0.1003).</p><p><strong>Conclusions: </strong>Rescue therapy with 10 kHz stimulation could be an important strategy to avoid SCS explant in both patients non-responsive during trial or experiencing a loss of efficacy during the years with other waveforms.</p>","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140336505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Pregabalin in patients with post-traumatic peripheral neuropathic pain: A meta-analysis of randomized controlled trials". 关于 "普瑞巴林对创伤后周围神经痛患者的治疗:随机对照试验荟萃分析"。
IF 2.5 3区 医学
Pain Practice Pub Date : 2024-07-01 Epub Date: 2024-03-09 DOI: 10.1111/papr.13361
I-Wen Chen, Chia-Li Kao, Kuo-Chuan Hung
{"title":"Comment on \"Pregabalin in patients with post-traumatic peripheral neuropathic pain: A meta-analysis of randomized controlled trials\".","authors":"I-Wen Chen, Chia-Li Kao, Kuo-Chuan Hung","doi":"10.1111/papr.13361","DOIUrl":"10.1111/papr.13361","url":null,"abstract":"","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140065667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrathecal drug delivery systems for cancer pain: Considerations for device type and indication. 治疗癌痛的鞘内给药系统:设备类型和适应症的考虑因素。
IF 2.5 3区 医学
Pain Practice Pub Date : 2024-07-01 Epub Date: 2024-03-26 DOI: 10.1111/papr.13368
Taif Mukhdomi, Bennett Andrassy, Junaid Mukhdomi
{"title":"Intrathecal drug delivery systems for cancer pain: Considerations for device type and indication.","authors":"Taif Mukhdomi, Bennett Andrassy, Junaid Mukhdomi","doi":"10.1111/papr.13368","DOIUrl":"10.1111/papr.13368","url":null,"abstract":"","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140288753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regarding Yalçınkaya et al.'s "Ossified/sequestrated lumbar disc: A ricochet in diffuse idiopathic skeletal hyperostosis". 关于 Yalçınkaya 等人的 "腰椎间盘骨化/嵌塞:弥漫性特发性骨骼增生症中的跳椎"。
IF 2.6 3区 医学
Pain Practice Pub Date : 2024-06-01 Epub Date: 2024-01-04 DOI: 10.1111/papr.13344
Min Cheol Chang
{"title":"Regarding Yalçınkaya et al.'s \"Ossified/sequestrated lumbar disc: A ricochet in diffuse idiopathic skeletal hyperostosis\".","authors":"Min Cheol Chang","doi":"10.1111/papr.13344","DOIUrl":"10.1111/papr.13344","url":null,"abstract":"","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139088019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of head and face pain decreased from 1997 to 2017 in Switzerland. 从 1997 年到 2017 年,瑞士头面部疼痛的发病率有所下降。
IF 2.6 3区 医学
Pain Practice Pub Date : 2024-06-01 Epub Date: 2024-01-22 DOI: 10.1111/papr.13346
Heiko Pohl, Maria Susanne Neumeier, Martin Hänsel, Susanne Wegener
{"title":"The prevalence of head and face pain decreased from 1997 to 2017 in Switzerland.","authors":"Heiko Pohl, Maria Susanne Neumeier, Martin Hänsel, Susanne Wegener","doi":"10.1111/papr.13346","DOIUrl":"10.1111/papr.13346","url":null,"abstract":"<p><strong>Background: </strong>Pain in the head and the face is highly prevalent but may have changed during the past years. This study aimed to analyze changes in the prevalence of pain in the head and the face in Switzerland from 1997 to 2017.</p><p><strong>Methods: </strong>This is a secondary analysis of data collected in the Swiss Health Surveys of 1997-2017. Included persons were 15 years and older. Besides studying demographic data, we analyze the item assessing the presence of \"headache, pressure in the head, or facial pain\" during the past 4 weeks. Percentages with their Wilson confidence intervals are reported for each response option of categorical variables. Moreover, we calculate the age-standardized number of persons affected by the pain.</p><p><strong>Results: </strong>While 41% reported head and face pain in 1997, the proportion dropped to 31% in 2017. There was a decrease of 19.5% in women and 29.4% in men; after age standardization, the decrease was 16.5% in women and 25.4% in men. The most considerable numerical changes in the percentages of women with pain occurred in those aged 55-69 and 85 and above. In men, the changes were not limited to specific age groups.</p><p><strong>Conclusions: </strong>The proportion of people reporting headaches, pressure in the head, or facial pain has dropped in Switzerland from 1997 to 2017. However, in women, the prevalence diminished more strongly and consistently in the middle-aged and the elderly than in the young.</p>","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139513427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信